The Quickening Pace of Oncology Research

Author:
Rodger J. Winn
Search for other papers by Rodger J. Winn in
Current site
Google Scholar
PubMed Close
 MD
Volume/Issue:
Volume 2: Issue 4
Online Publication Date:
Jul 2004
DOI:
https://doi.org/10.6004/jnccn.2004.0024
Full access

Rodger J. Winn is the Editor-in-Chief of JNCCN. His past positions include Associate Professor of Clinical Medicine at the University of Texas M. D. Anderson Cancer Center. Dr. Winn received his medical degree from Jefferson Medical College of Philadelphia. His postgraduate training includes an internship and residency at Jefferson Medical College, and he also completed a medical oncology fellowship at Memorial Sloan-Kettering Cancer Center in New York. He is board certified in internal medicine and holds subspecialty certification in oncology.

  • Collapse
  • Expand
Print ISSN:
1540-1405
Online ISSN:
1540-1413
Publisher:
National Comprehensive Cancer Network
Cover Journal of the National Comprehensive Cancer Network
  • 1

    Singhal S, Mehta J, Desikan R et al.. Antitumor activity of thalidomide in refractory multiple myeloma. N Engl J Med 1999;341:1565-1571.

  • 2

    Richardson PG, Barlogie B, Bertenson J et al.. A Phase 2 study of bortezomib in relapsed, refractory myeloma. N Engl J Med 2003;348:2609-2617.

Copyright:
Copyright © 2004 by the National Comprehensive Cancer Network 2004
Page Numbers:
2
Article Category:
Editorial
Print Publication Date:
01 Jul 2004
Online Publication Date:
Jul 2004

Metrics

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 477 346 32
PDF Downloads 63 15 2
EPUB Downloads 0 0 0